Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Prevention of Arrhythmia Device Infection Trial

Open access
Krahn, Andrew D., Longtin, Yves, Philippon, François, Birnie, David H., Manlucu, Jaimie, Angaran, Paul, Rinne, Claus, Coutu, Benoit, Low, R. Aaron, Essebag, Vidal, Morillo, Carlos, Redfearn, Damian, Toal, Satish, Becker, Giuliano, Degrâce, Michel, Thibault, Bernard, Crystal, Eugene, Tung, Stanley, LeMaitre, John, Sultan, Omar, Bennett, Matthew, Bashir, Jamil, Ayala-Paredes, Felix, Gervais, Philippe, Rioux, Leon, Hemels, Martin E.W., Bouwels, Leon H.R., van Vlies, Bob, Wang, Jia, Exner, Derek V., Dorian, Paul, Parkash, Ratika, Alings, Marco, Connolly, Stuart J. · 2018 · Journal of the American College of Cardiology

Abstract

BACKGROUND Infection of implanted medical devices has catastrophic consequences. For cardiac rhythm devices, pre-procedural cefazolin is standard prophylaxis but does not protect against methicillin-resistant gram-positive organisms, which are common pathogens in device infections. OBJECTIVE This study tested the clinical effectiveness of incremental perioperative antibiotics to reduce device infection. METHODS The authors performed a cluster randomized crossover trial with 4 randomly assigned 6-month periods, during which centers used either conventional or incremental periprocedural antibiotics for all cardiac implantable electronic device procedures as standard procedure. Conventional treatment was pre-procedural cefazolin infusion. Incremental treatment was pre-procedural cefazolin plus vancomycin, intraprocedural bacitracin pocket wash, and 2-day post-procedural oral cephalexin. The primary outcome was 1-year hospitalization for device infection in the high-risk group, analyzed by hierarchical logistic regression modeling, adjusting for random cluster and cluster-period effects. RESULTS Device procedures were performed in 28 centers in 19,603 patients, of whom 12,842 were high risk. Infection occurred in 99 patients (1.03%) receiving conventional treatment, and in 78 (0.78%) receiving incremental treatment (odds ratio: 0.77; 95% confidence interval: 0.56 to 1.05; p = 0.10). In high-risk patients, hospitalization for infection occurred in 77 patients (1.23%) receiving conventional antibiotics and in 66 (1.01%) receiving incremental antibiotics (odds ratio: 0.82; 95% confidence interval: 0.59 to 1.15; p = 0.26). Subgroup analysis did not identify relevant patient or site characteristics with significant benefit from incremental therapy. CONCLUSIONS The cluster crossover design efficiently tested clinical effectiveness of incremental antibiotics to reduce device infection. Device infection rates were low. The observed difference in infection rates was not statistically significant. (Prevention of Arrhythmia Device Infection Trial [PADIT Pilot] [PADIT]; NCT01002911).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.09.068

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 260

Metadata

Authors
Krahn, A. D., Longtin, Y., Philippon, F., Birnie, D. H., Manlucu, J., Angaran, P., Rinne, C., Coutu, B., Low, R. A., Essebag, V., Morillo, C., Redfearn, D., Toal, S., Becker, G., Degrâce, M., Thibault, B., Crystal, E., Tung, S., LeMaitre, J., Sultan, O., Bennett, M., Bashir, J., Ayala-Paredes, F., Gervais, P., Rioux, L., Hemels, M. E. W., Bouwels, L. H. R., van Vlies, B., Wang, J., Exner, D. V., Dorian, P., Parkash, R., Alings, M., & Connolly, S. J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2018-12
Volume
72
Issue
24
Pages
3098-3109
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2903848086
Cited by
260
References
24
FWCI
15.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of Arrhythmia Device Infection Trial. https://app.cochat.ai/papers/10.1016/j.jacc.2018.09.068
The paper
Krahn, A. D., Longtin, Y., Philippon, F., Birnie, D. H., Manlucu, J., Angaran, P., Rinne, C., Coutu, B., Low, R. A., Essebag, V., Morillo, C., Redfearn, D., Toal, S., Becker, G., Degrâce, M., Thibault, B., Crystal, E., Tung, S., LeMaitre, J., . . . Connolly, S. J. (2018). Prevention of Arrhythmia Device Infection Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2018.09.068

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.